SGLT2抑制剂对2型糖尿病患者的心血管保护作用(3)
[5]Zinman B,Lachin JM,Inzucchi SE.Empagliflozin,Cardiovascular Outcomes,and Mortality in Type 2 Diabetes[J].N Engl J Med,2016,374(11):1093-1094.[6]Wong DT,Puri R,Richardson JD,et al.Myocardial'no-reflow'-diagnosis,pathophysiology and treatment[J].Int J Cardiol,2013,167(5):1798-1806
[7]Llaurado G ......
您现在查看是摘要页,全文长 2787 字符。